**Question:** Mycobacterium causing lung infection are:

A) Mycobacterium Tuberculosis
B) Mycobacterium Kansasii
C) Mycobacterium Fortuitum
D) Mycobacterium avium intracellularae
E) Mycobacterium Scrofulocellular

**Correct Answer:**

**Core Concept:** Mycobacterium are a group of gram-positive, rod-shaped bacteria that can cause various infections in humans, particularly in the lungs. They are part of the mycobacterial family, which includes both pathogenic and non-pathogenic species.

**Why the Correct Answer is Right:**

The correct answer, Mycobacterium Tuberculosis (A), is responsible for the most common and well-known lung infection, tuberculosis (TB). TB is a severe and often fatal disease that primarily affects the lungs, although it can also involve other organs. Mycobacterium Tuberculosis is a significant global health issue, with ~10 million new cases and 1.5 million deaths in 2020.

**Why Each Wrong Option is Incorrect:**

B) Mycobacterium Kansasii (B) is another pathogenic mycobacterium that can cause lung infections, but it is less common than TB and less well-known.

C) Mycobacterium Fortuitum (C) is a group of mycobacteria that are opportunistic pathogens, meaning they can cause infections in immunocompromised individuals or in specific environmental conditions. While some strains can cause lung infections, Mycobacterium Fortuitum is not as pathogenic as TB or Kansasii.

D) Mycobacterium avium intracellularae (D) is another opportunistic pathogen, primarily affecting immunocompromised individuals. Although it can cause lung infections, it is less common than the previously mentioned mycobacteria.

E) Mycobacterium Scrofulocellular (E) is a non-pathogenic mycobacterium, not causing infections in humans.

**Core Concept:** Mycobacterium species are responsible for various infections, including lung infections.

**Clinical Pearls:** Understanding the differences between these mycobacteria is crucial for diagnosing and treating infections accurately. It is essential to consider the clinical context (e.g., immunocompromised status) when determining the most likely causative agent.

In conclusion, recognizing the differences between these mycobacteria helps in determining the appropriate diagnosis and treatment options for patients presenting with lung infections.